Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Controlled trial examines efficacy of embryonic dopamine neuron transplantation in PD

March 15, 2001

Nastech's nasal triptan enters phase I for migraine pain

March 15, 2001

Metabotropic glutamate receptor antagonists and their use

March 14, 2001

Neuroprotective series claimed by Vernalis

March 14, 2001

Caspase inhibitors specifically claimed by Merck for Alzheimer's disease

March 13, 2001

Durect accelerates development of DUROS pain product

March 13, 2001

ASCPT news: GW-320659 has favorable PK and drug interaction profile in man

March 13, 2001

Atrix/Elan joint venture begins development of antiemetic product

March 13, 2001

Analgesic compounds claimed in international patent by Gruenenthal

March 12, 2001

Recent patent describes metabolite of MDL-100907 and its use in schizophrenia, anxiety, etc.

March 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....